Bio-Immunoassay for Staphylokinase in Blood

Summary

A bio-immunoassay (BIA) for the determination of staphy-lokinase (STA) activity in a plasma milieu has been developed. MA-7H11, a murine monoclonal antibody raised against STA, which has a high affinity for STA but does not interfere with the complex formation between plasmin(ogen) and STA or with plasminogen activation by STA, was coated on microtiter plates at a concentration of 4 μg/ml. STA-containing samples were incubated overnight at 4° C and, after extensive washing, bound STA was quantitated by incubation with plasminogen (final concentration 0.5 μM) for 1 h at 37°C, followed by determination of generated plasmin from the absorbance at 405 nm 10 min after addition of the chromogenic substrate S-2403 (final concentration 0.3 mM). Calibration curves constructed with natural (STAN) or recombinant (STAR) STA were linear between approximately 1 and 10 nM, with a lower detection limit of ≤ 1 nM in buffer and in plasma of the human, baboon or hamster.

Following bolus injection of STAR in hamsters, the disposition rate of STAR activity from plasma, determined with the BIA correlated very well (r = 0.98) with that of STAR-related antigen determined by ELISA, indicating that STAR is cleared in a functionally active form. The initial half-life was about 2 min, as determined with both methods. Following continuous intravenous infusion over 1 h in baboons, the plasma clearance of STAR activity, determined from the infusion rate and the steady-state plasma level of STAR activity, ranged between 45 and 62 ml/min for doses of STAR between 0.063 and 0.250 mg/kg.

• References

• 1 Lack CH. Staphylokinase: an activator of plasma protease. Nature 1948; 161: 559-560
• 2 Lewis JH, Ferguson JH. A proteolytic enzyme system of the blood. III. Activation of dog serum profibrinolysin by staphylokinase. Am J Physiol 1951; 166: 594-603
• 3 Kowalska-Loth B, Zakrzewski K. The activation by staphylokinase of human plasminogen. Acta Biochim Pol 1975; 22: 327-339
• 4 Ericson R. The mechanism of the activation of plasminogen by staphylokinase. Chem Abstr 1977; 86: 202 (abstract 67386Z)
• 5 Lijnen HR, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O, Collen D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 1991; 266: 11826-11832
• 6 Sakai M, Watanuki M, Matsuo O. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of α₂-plasmin inhibitor. Biochem Biophys Res Commun 1989; 162: 830-837
• 7 Matsuo O, Okada K, Fukao H, Tomioka Y, Ueshima S, Watanuki M, Sakai M. Thrombolytic properties of staphylokinase. Blood 1990; 76: 925-929
• 8 Lewis JH, Kerber CW, Wilson JH. Effects of fibrinolytic agents and heparin on intravascular clot lysis. Am J Physiol 1964; 207: 1044-1048
• 9 Kanai K. Fibrinolysis by staphylokinase in vivo. Biol Abstr 1986; 81: 748 (abstract 65436)
• 10 Lijnen HR, Stassen JM, Vanlinthout I, Fukao H, Okada K, Matsuo O, Collen D. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Thromb Haemostas 1991; 66: 468-473
• 11 Lijnen HR, Van Hoef B, Vandenbossche L, Collen D. Biochemical properties of natural and recombinant staphylokinase. Fibrinolysis 1992; 6: 214-225
• 12 Collen D, De Cock F, Vanlinthout I, Declerck PJ, Lijnen HR, Stassen JM. Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase. Fibrinolysis 1992; 6: 232-242
• 13 Collen D, De Cock F, Stassen JM. Comparative immunogenicity and thrombolytic properties towards arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons. Circulation 1993; 87: 996-1006
• 14 Collen D, Van de Werf F. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctíon. Circulation 1993; 87: 1850-1853
• 15 Collen D, Silence K, Demarsin E, De Mol M, Lijnen HR. Isolation’ and characterization of natural and recombinant staphylokinase. Fibrinolysis 1992; 6: 203-213
• 16 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 17 Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 18 Lijnen HR, Van Hoef B, Collen D. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator. Biochim Biophys Acta 1986; 884: 402-408
• 19 Wiman B. Primary structure of the B-chain of human plasmin. Eur J Biochem 1977; 76: 129-137
• 20 Declerck PJ, Lijnen HR, Verstreken M, Moreau H, Collen D. A monoclonal antibody specific for two chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma. Blood 1990; 75: 1794-1800
• 21 Hogg PJ, Johnston SC, Bowles MR, Pond SM, Winsor DJ. Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: the binding of paraquat to its elicited mouse monoclonal antibody. Mol Immunol 1987; 24: 797-801
• 22 Lijnen HR, De Cock F, Matsuo O, Collen D. Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro. Fibrinolysis 1992; 6: 33-37
• 23 Silence K, Collen D, Lijnen HR. Interaction between staphylokinase, plasmin(ogen) and α₂-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by α₂-antiplasmin. J Biol Chem 1993; 268: 9811-9816
• 24 Silence K, Collen D, Lijnen HR. Regulation by α₂-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Blood. 1993 (in press)